MedPath
NMPA Approval

Sulfadiazine Sodium Injection

国药准字H41023475

March 5, 2024

Drug Information

磺胺嘧啶钠注射液

注射剂

5ml:1g

化学药品

March 5, 2024

Company Information

Applicant Company

安阳市汤阴产业集聚区扁鹊路

Manufacturing Company

安阳市汤阴产业集聚区扁鹊路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磺胺嘧啶钠注射液 - NMPA 批准文号 | MedPath